AAAAAA
Results:
1-17
|
Results: 17
Authors:
COLLINS RH
SHPILBERG O
DROBYSKI WR
PORTER DL
GIRALT S
CHAMPLIN R
GOODMAN SA
WOLFF SN
HU W
VERFAILLIE C
LIST A
DALTON W
OGNOSKIE N
CHETRIT A
ANTIN JH
NEMUNAITIS J
Citation: Rh. Collins et al., DONOR LEUKOCYTE INFUSIONS IN 140 PATIENTS WITH RELAPSED MALIGNANCY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Journal of clinical oncology, 15(2), 1997, pp. 433-444
Authors:
STIFF P
EMMANOUILIDES C
LUGER S
HARMAN G
LEMAISTRE CF
BROWN R
PERRY J
MASON JR
LIST A
BENSINGER W
FRETER D
SCHENKEIN D
BRANNAN C
OLSON E
WYRES M
WHEELER C
Citation: P. Stiff et al., USE OF STEM-CELL FACTOR PLUS FILGRASTIM IMPROVES PBPC COLLECTION IN HEAVILY PRETREATED PATIENTS WITH LYMPHOMA OR HODGKINS-DISEASE, Experimental hematology, 25(8), 1997, pp. 359-359
Authors:
STIFF P
GINGRICH R
LUGER S
BROWN RA
LEMAISTRE CF
PERRY J
SCHENKEIN D
LIST A
MASON JR
BENSINGER W
WHEELER CA
FRETER C
MURPHYFILKINS R
WYRES M
PARKER W
EMMANOUILIDES C
Citation: P. Stiff et al., IMPROVED PBPC COLLECTION USING STEMGEN(R) (STEM-CELL FACTOR, SCF) ANDFILGRASTIM (G-CSF) COMPARED TO G-CSF ALONE IN HEAVILY PRETREATED LYMPHOMA (NNL) AND HODGKINS-DISEASE (HD) PATIENTS (PTS), Blood, 90(10), 1997, pp. 2628-2628
Authors:
ROSENFELD CS
BOLWELL B
LEFEVER A
TAYLOR R
LIST A
FAY J
COLLINS R
ANDREWS F
PALLANSCH P
SCHUSTER MW
RESTA D
LEVITT D
NEMUNAITIS J
Citation: Cs. Rosenfeld et al., COMPARISON OF 4 CYTOKINE REGIMENS FOR MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS - IL-3 ALONE AND COMBINED WITH GM-CSF OR G-CSF, Bone marrow transplantation, 17(2), 1996, pp. 179-183
Authors:
SINGER JW
LIST A
FEDERIGHI D
MICHNICK T
BURSTEN S
Citation: Jw. Singer et al., SERUM HYDROPEROXY AND HYDROXYOCTADECADIENOIC ACIDS (HPODE AND HODE) INCREASE IN RESPONSE TO TOTAL-BODY IRRADIATION (TBJ) AND ARE SUPPRESSEDBY LISOFYLLINE (LSF) IN ALLOGENIC BMT PATIENTS, Blood, 88(10), 1996, pp. 1820-1820
Authors:
LIST A
MAZIARZ R
STIFF P
JANSEN J
LIESFELD J
SCHUSTER M
ANDREWS DF
KARANES I
WOLF S
LITZOW M
Citation: A. List et al., LISOFYLLINE (LSF) REDUCES INFECTION-RATE AND IMPROVES SURVIVAL IN PTSUNDERGOING ALLOGENIC BONE-MARROW TRANSPLANTATION (BMT) - RESULTS OF ARANDOMIZED, PLACEBO-CONTROLLED TRIAL, Blood, 88(10), 1996, pp. 1825-1825
Authors:
SCHUCHTER L
DIPAOLA R
GREENBERG R
BIRD S
MOLLMAN J
RECIO A
LIST A
TAYLOR C
ALBERTS D
Citation: L. Schuchter et al., A PHASE-I STUDY OF AMIFOSTINE (AMI) AND ESCALATING DOSES OF TAXOL IN PATIENTS (PTS) WITH ADVANCED CANCER, European journal of cancer, 31A, 1995, pp. 958-958
Authors:
BOCHMANN RP
REUTER U
LIST A
GRUNDIG M
SINZ V
Citation: Rp. Bochmann et al., COMPLIANCE OF THE DIGITAL ARTERY IS DECREASED IN PATIENTS WITH ESSENTIAL-HYPERTENSION, Journal of human hypertension, 9(8), 1995, pp. 627-631
Authors:
SALMON SE
MILLER TP
GROGAN T
LIST A
DALTON WS
Citation: Se. Salmon et al., REVERSAL OF MULTIDRUG-RESISTANCE (MDR) WITH CHEMOSENSITIZERS - AN EMERGING CLINICAL REALITY, Journal of cellular biochemistry, 1994, pp. 100-100
Authors:
SCHUSTER M
NEMUNAITIS J
LIST A
KURTZBERG J
FLOMENBERG N
SINGER JW
BIANCO JA
Citation: M. Schuster et al., LISOFYLLINE, A PHOSPHOLIPID SIGNALING INHIBITOR APPEARS TO ACCELERATETRILINEAGE ENGRAFTMENT FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Experimental hematology, 22(8), 1994, pp. 697-697
Authors:
ABBASZADEGAN MR
FUTSCHER BW
KLIMECKI WT
LIST A
DALTON WS
Citation: Mr. Abbaszadegan et al., ANALYSIS OF MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) MESSENGER-RNA IN NORMAL AND MALIGNANT HEMATOPOIETIC-CELLS, Cancer research, 54(17), 1994, pp. 4676-4679
Authors:
RUSSELL M
LIST A
GREENBERG P
WOODWARD S
GLINSMANN B
PARGANAS E
IHLE J
TAETLE R
Citation: M. Russell et al., EXPRESSION OF EVI1 IN MYELODYSPLASTIC SYNDROMES AND OTHER HEMATOLOGICMALIGNANCIES WITHOUT 3Q26 TRANSLOCATIONS, Blood, 84(4), 1994, pp. 1243-1248
Authors:
LIST A
SHUSTER M
BLAZAR B
ELFENBEIN G
NEMUNAITIS J
FLOMENBERG N
KURTZBERG J
BAKKE L
THOELKE K
SINGER JW
BIANCO JA
Citation: A. List et al., PHASE-I CONCENTRATION-CONTROLLED, ESCALATION TRIAL OF LISOFYLLINE (LSF) IN PATIENTS (PTS) UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION(BMT), Blood, 84(10), 1994, pp. 10000089-10000089
Authors:
BOLWELL B
ROSENFELD C
LEFEVER A
LIST A
ANDREWS F
SCHUSTER M
LEVITT D
RESTA D
GEORGE M
NEMUNAITIS J
COLLINS R
Citation: B. Bolwell et al., A PHASE-II TRIAL OF G-CSF WITH OR WITHOUT SDZ ILE-964 (IL-3) FOR THE MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) FOR AUTOLOGOUS PROGENITOR-CELL TRANSPLANTATION, Blood, 84(10), 1994, pp. 10000106-10000106
Authors:
COLLINS R
WOLFF S
LIST A
CHRISTIANSEN N
PINEIRO L
GREER J
GOODMAN S
DALTON W
GONZALEZ G
HERZIG G
PHILLIPS G
FAY J
Citation: R. Collins et al., PROSPECTIVE MULTICENTER TRIAL OF DONOR BUFFY COAT INFUSION FOR RELAPSED HEMATOLOGIC MALIGNANCY POST-ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT), Blood, 84(10), 1994, pp. 10000333-10000333
Authors:
MAITI D
LIST A
DOBRES MS
Citation: D. Maiti et al., TRANSCRIPTS FOR A LECTIN-LIKE GENE ACCUMULATE IN THE EPIDERMIS BUT NOT THE PROTODERMIS OF THE PEA SHOOT APEX, Planta, 190(2), 1993, pp. 241-246
Authors:
NEMUNAITIS J
ROSENFELD C
BOLWELL B
LEFEVER A
TAYLOR R
FAY J
COLLINS R
LIST A
SCHUSTER M
RESTA D
PALLANSCH P
LEVITT D
Citation: J. Nemunaitis et al., PHASE-II RANDOMIZED TRIAL COMPARING SDZ-ILE-964 (RHIL-3) TO SEQUENTIAL AND COMBINATION ADMINISTRATION OF RHIL-3 AND LEUKINE(R) OR NEUPOGEN(R) IN THE MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS FOR AUTOLOGOUS TRANSPLANT (PBSCT) IN PATIENTS WITH LYMPHOID MALIGNANCY OR BREAST-CANCER, Blood, 82(10), 1993, pp. 10000365-10000365
Risultati:
1-17
|